Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects
Clinical trial NCT06609525 · UNKNOWN
Trial details
- NCT number
- NCT06609525
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-09
- Primary completion
- 2024-12-31
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.